BeStock  
Stocks › Biotechnology › OCUL

Ocular Therapeutix OCUL

US equityMarket cap rank #2935Biotechnology
$7.25 +$0.29 (+4.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $7.25 -0.02%
Open$6.93
Prev close$6.96
Day range$6.79 – $7.27
Volume5.62M
Market cap$1.59B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±6.5%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+6.1%
Worst reaction-17.0%

Stock move on the day after each report

+2.3%2023/Q1-10.8%2023/Q2-13.2%2023/Q3-4.5%2023/Q4-3.0%2024/Q1+6.1%2024/Q2-6.4%2024/Q3-17.0%2024/Q4-12.2%2025/Q1-2.8%2025/Q2-4.5%2025/Q3-0.6%2026/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q15 May 2026Pre Market±12.8%-0.61%Within range
2025/Q34 Nov 2025Pre Market±11.0%-4.47%Within range
2025/Q25 Aug 2025Pre Market±15.7%-2.83%Within range
2025/Q15 May 2025Pre Market±14.4%-12.16%Within range
2024/Q43 Mar 2025Pre Market±19.9%-17.02%Within range
2024/Q314 Nov 2024Pre Market±15.3%-6.42%Within range
2024/Q27 Aug 2024Pre Market±23.1%+6.08%Within range
2024/Q17 May 2024After Market±16.7%-3.04%Within range
2023/Q411 Mar 2024After Market±13.8%-4.52%Within range
2023/Q37 Nov 2023After Market±21.4%-13.20%Within range
2023/Q27 Aug 2023After Market±22.3%-10.78%Within range
2023/Q18 May 2023After Market±19.2%+2.34%Within range
2022/Q46 Mar 2023After Market±14.4%+5.29%Within range
2022/Q37 Nov 2022After Market±23.8%-10.99%Within range
2022/Q28 Aug 2022After Market±25.8%-2.96%Within range
2022/Q19 May 2022None±29.1%+1.84%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$51.95M-18.5% YoY
Operating profit-$270.02M-57.2% YoY
Net profit-$265.94M-37.4% YoY
Diluted EPS-$1.42-16.4% YoY

Profitability & balance sheet

Gross margin87.3%
Operating margin-519.8%
Net margin-511.9%

Discussion

No comments yet — be the first to weigh in on OCUL.

Leave a comment

Scroll to Top